79
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Changes in Melanin and Melanocytes in Mottled Hypopigmentation after Low-Fluence 1,064-nm Q-Switched Nd:YAG Laser Treatment for Melasma

      letter

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Dear Editor: Melasma is a common acquired hyperpigmentary disorder of the face, but its treatment remains challenging. A procedure called "laser toning" that uses a low-energy 1064-nm Q-switched Nd:YAG laser was recently introduced for the treatment of melasma, demonstrating good results1,2,3. However, the possibility of mottled hypopigmentation is a major concern with this treatment, because it rarely recovers spontaneously4. The underlying mechanisms of mottled hypopigmentation are not completely understood. Whether the hypopigmentation is caused by reduced pigmentation with intact melanocytes or a decrease or absence of melanocytes remains to be elucidated. Therefore, this study investigated the changes in melanin and melanocytes in hypopigmented lesions that develop after low-fluence 1,064-nm Q-switched Nd:YAG laser treatment for melasma. This study was approved by the institutional review board of Ajou University Hospital (AJIRB-MED-KSP-12-374). Patient 1, a 41-year-old woman with Fitzpatrick skin type IV, presented with typical mottled hypopigmentation after treatment with 1,064-nm Q-switched Nd:YAG laser for melasma (Fig. 1A). The duration of hypopigmentation was 7 years. Skin biopsies were obtained from the hypopigmented, hyperpigmented (i.e., melasma), and adjacent perilesional normal skin areas. Hematoxylin and eosin and Fontana-Masson staining as well as immunohistochemical staining using melanocyte-specific markers including monoclonal antibodies against human gp100 (NKI/ beteb; Monosan, Uden, the Netherlands), tyrosinase (Thermo Scientific, Fremont, CA, USA), and microphthalmia-associated transcription factor (MITF; Leica Biosystems, Newcastle, UK) were performed. The numbers of MITF+ melanocytes per 1-mm length of rete ridge were counted. The expression levels of gp100 and tyrosinase were measured as the ratio of stained area to measured epidermal area. The general histological findings of the hypopigmented skin were unremarkable. There was no collagen remodeling or scarring. Fontana-Masson staining demonstrated the almost complete absence of melanin pigment in hypopigmented skin (Fig. 1B). The number of melanocytes, as determined by MITF expression, was not substantially different in lesional skin (n=4) compared to perilesional normal skin (n=5) or melasma skin (n=3). Consistently, tyrosinase level was not lower in lesional skin than perilesional normal skin but was higher than that in melasma skin as expected. Interestingly, gp100 expression was higher in the hypopigmented lesion than perilesional normal skin and even melasma skin. Similar findings were observed in patient 2, a 49-year-old woman with Fitzpatrick skin type III who presented with typical mottled hypopigmentation after laser toning for 1 year (Fig. 2A). Lesional skin biopsy showed the complete absence of melanin pigment in hypopigmented skin. However, there was no reduction in the number of melanocytes, and gp100 expression was elevated (Fig. 2B). The results of the present study clearly demonstrate that the histologic features of laser toning-induced hypopigmentation are characterized by almost destroyed melanosome pigments and a preserved the number of melanocytes. However, it is unclear whether the number of melanocytes is reduced in the hypopigmented skin. One study indicates hypopigmentation might be due to melanocytopenia5. However, in that study, lesional skin was not compared with adjacent perilesional normal skin. The other studies suggest the number of melanocytes in hypopigmented skin is normal6,7. In the present study, there was no difference in the mean numbers of MITF-stained melanocytes between lesional skin and perilesional normal skin. Interestingly, we noticed that the levels of the structural protein gp100 were preserved and rather elevated in lesional skin compared to perilesional normal skin. Moreover, in patient 1, gp100 levels of hypopigmented skin were clearly elevated compared to that in hyperpigmented skin. Although the reason for this result is unclear, these findings nonetheless suggest the melanogenic activity in the melanocytes was impaired and the cells failed to produce fully matured melanosomes. Considering that the proposed action mechanism of laser toning is subcellular selective photothermolysis of melanosomes and not melanocytes, it is speculated that melanocytes survived but were functionally downregulated such that they did not produce fully matured melanosomes. The cumulative dose of repetitive laser treatment may affect melanocyte function, resulting in the development of hypopigmentation. Therefore, treatment activating or stimulating melanogenesis in the melanocytes would be required. To this end, treatment with focused narrowband ultraviolet B therapy has been used with some success8. In conclusion, laser toning-induced hypopigmentation is characterized by almost destroyed melanosome pigments and a preserved number of melanocytes, which seem to be functionally downregulated not to produce fully matured melanosomes. Thus, early intervention aiming to restore melanocyte function would be required.

          Related collections

          Most cited references9

          • Record: found
          • Abstract: found
          • Article: not found

          A case series of facial depigmentation associated with low fluence Q-switched 1,064 nm Nd:YAG laser for skin rejuvenation and melasma.

          In recent years, "laser toning" using low fluence, large spot size, multiple passed Q-switched 1,064 nm Nd:YAG laser has gained much popularity in Asian countries for non-ablative skin rejuvenation and the treatment of melasma. This case series highlights one of the complications associated with laser toning, which is facial depigmentation. Fourteen patients with laser toning-associated facial depigmentation were assessed with cross-polarized and ultraviolet (UV) photographic images. The laser toning regimens received by these patients, as well as the treatment given for depigmentation, were analyzed retrospectively. All 14 patients were Chinese females, 9 of whom received laser toning for non-ablative skin rejuvenation and the other 5 for melasma. The treatment regimens received by these patients were highly variable. The total number of treatments received ranged from 6 to 50 (mean 22.07). In all cases, UV photographic images demonstrated facial mottled depigmentation. Laser toning failed to significantly improve melasma in all five patients. Five patients received targeted narrowband UVB for depigmentation with good clinical results. Laser toning with low fluence Q-switched 1,064 nm Nd:YAG laser for skin rejuvenation and melasma can be associated with mottled depigmentation. With laser toning being frequently performed, this complication may become more commonly encountered in clinical practice. The depigmentation can appear after only a few treatment sessions, and can cause much disfigurement, especially in cases with background melasma. Further studies on laser toning are needed with the view to optimizing efficacy and minimizing side-effects. © 2010 Wiley-Liss, Inc.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Treatment of refractory dermal melasma with the MedLite C6 Q-switched Nd:YAG laser: two case reports.

            Dermal melasma in Fitzpatrick skin types III-V usually does not respond to topical treatments. Laser resurfacing often either fails to treat these lesions or results in severe postinflammatory hyperpigmentation (PIH) or permanent hypopigmentation. Two cases of refractory dermal melasma are reported, which responded to treatment with the MedLite C6 Q-switched Nd:YAG laser. Case 1: A 50-year-old Asian female with refractory dermal melasma and severe PIH received 10 weekly laser treatments combined with 7% alpha arbutin and a broad-spectrum sunscreen. Case 2: A 45-year-old Asian female with refractory dermal melasma received 10 weekly laser treatments combined with 7% alpha arbutin and a broad-spectrum sunscreen. In both cases, there was a greater than 80% reduction in epidermal and dermal hyperpigmentation. The melanin index at the site of the lesions decreased from 50 to 35 and 45 to 33, respectively. There was no recurrence of melasma at 1 year (case 1) or 6 months (case 2). Even in cases of long-standing refractory dermal melasma in a darker skin type, combination therapy has been shown to be an effective treatment for this difficult condition.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Melasma treatment in Korean women using a 1064-nm Q-switched Nd:YAG laser with low pulse energy.

              The efficacy of a 1064-nm Q-switched neodymium:yttrium-aluminium-garnet (QS Nd:YAG) laser with low pulse energy in the treatment of melasma in 25 women was assessed by retrospective analysis of clinical photographs and patient satisfaction rates. Follow-up results 2 months after the last treatment revealed that, as defined by our grading scale, 11 of the 25 patients (44%) had marked clinical improvement: 7 of these (28%) had near-total clinical improvement, 5 had moderate clinical improvement and 2 had minimal to no improvement. Our data suggest that the use of a QS Nd:YAG laser with low pulse energy is an effective, easily performed treatment for melasma in selected East Asian patients.
                Bookmark

                Author and article information

                Journal
                Ann Dermatol
                Ann Dermatol
                AD
                Annals of Dermatology
                Korean Dermatological Association; The Korean Society for Investigative Dermatology
                1013-9087
                2005-3894
                June 2015
                29 May 2015
                : 27
                : 3
                : 340-342
                Affiliations
                Department of Dermatology, Kyungpook National University School of Medicine, Daegu, Korea.
                [1 ]Department of Dermatology, Ajou University School of Medicine, Suwon, Korea.
                Author notes
                Corresponding author: Hee Young Kang, Department of Dermatology, Ajou University School of Medicine, 164 World Cup-ro, Yeongtong-gu, Suwon 443-380, Korea. Tel: 82-31-219-5190, Fax: 82-31-219-5189, hykang@ 123456ajou.ac.kr
                Article
                10.5021/ad.2015.27.3.340
                4466296
                dae13451-c74a-41bc-a049-8ba2aff6a330
                Copyright © 2015 The Korean Dermatological Association and The Korean Society for Investigative Dermatology

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 30 May 2014
                : 25 June 2014
                : 10 July 2014
                Categories
                Letter to the Editor

                Dermatology
                Dermatology

                Comments

                Comment on this article